Login

Financial Snapshot

Revenue
TTM
$978.8M
Gross Margin
TTM
73.72%
Net Income
TTM
-$286.5M
Current Assets
2026 Q1
Current Liabilities
2026 Q1
Current Ratio
2026 Q1
127.8%
Total Assets
2026 Q1
Total Liabilities
2026 Q1
Book Value
2026 Q1
-$234.4M
Cash
2026 Q1
P/E
Last 4 Quarters
N/A
Free Cash Flow
TTM
-$35.90M

Stock Price

Loading...
Market Cap: $483.13 Million

About Claritev Corp

Claritev Corp (CTEV) is a company that, based on the available filing excerpts from its 10-K filed 2026-02-26 (accession 000179322926000017), does not provide sufficient detail in the extracted sections to construct a fully sourced canonical business description. The cover page and administrative sections of the filing were provided, but the business operations, revenue model, segment detail, and competitive positioning disclosures were not included in the excerpts supplied. No specific financial figures, product names, customer types, or market descriptions can be attributed to this filing without that underlying disclosure. A complete description requires the Item 1 Business section, Item 7 MD&A, and segment footnotes from the same filing.

Source: SEC 10-K, filed 2026-02-26

Industry: Services-Business Services, NEC Peers: Veradigm Inc. Certara Inc Definitive Healthcare Corp GoodRx Holdings Inc NEXTGEN HEALTHCARE, INC. Phreesia Inc Schrodinger Inc

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Premium Feature

This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.

Premium includes:

  • Unlimited historical financial data
  • Advanced analytics and insights
  • Priority support